🇺🇸 FDA

Intelligence Platform

Patents

Browse 991 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8618152

Inhibitors of serine proteases, particularly HCV NS3-NS4A proteases

Vertex Pharmaceuticals Incorporated · Granted Tue Dec 31 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8614327

Modulators of ATP-binding cassette transporters

Vertex Pharmaceuticals Incorporated · Granted Tue Dec 24 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8614325

Modulators of cystic fibrosis transmembrane conductance regulator

Vertex Pharmaceuticals Incorporated · Granted Tue Dec 24 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8609703

Modulators of ATP-binding cassette transporters

Vertex Pharmaceuticals Incorporated · Granted Tue Dec 17 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8604203

Modulators of cystic fibrosis transmembrane conductance regulator

Vertex Pharmaceuticals Incorporated · Granted Tue Dec 10 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8598361

Process for preparing 5-fluoro-1H-pyrazolo [3,4-B] pyridin-3-amine and derivatives therof

Vertex Pharmaceuticals Incorporated · Granted Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8598205

Modulators of cystic fibrosis transmembrane conductance regulator

Vertex Pharmaceuticals Incorporated · Granted Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8598164

Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channels

Vertex Pharmaceuticals Incorporated · Granted Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8598181

Modulators of ATP-binding cassette transporters

Vertex Pharmaceuticals Incorporated · Granted Tue Dec 03 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 28 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8592577

Methods for preparing pyrimidine derivatives useful as protein kinase inhibitors

Vertex Pharmaceuticals Incorporated · Granted Tue Nov 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8592602

Processes for producing cycloalkylcarboxamido-pyridine benzoic acids

Vertex Pharmaceuticals Incorporated · Granted Tue Nov 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8586615

Modulators of cystic fibrosis transmembrane conductance regulator

Vertex Pharmaceuticals Incorporated · Granted Tue Nov 19 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8586589

Piperidine and piperazine phenyl sulfonamides as modulators of ion channels

Vertex Pharmaceuticals Incorporated · Granted Tue Nov 19 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8580802

Pyrrolo[2,3-D]pyrimidines as inhibitors of Janus kinases

Vertex Pharmaceuticals Incorporated · Granted Tue Nov 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8575208

Inhibitors of serine proteases

Vertex Pharmaceuticals Incorporated · Granted Tue Nov 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8575209

Modulators of ATP-binding cassette transporters

Vertex Pharmaceuticals Incorporated · Granted Tue Nov 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8569337

Tri-cyclic pyrazolopyridine kinase inhibitors

Vertex Pharmaceuticals Incorporated · Granted Tue Oct 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8563573

Azaindole derivatives as CFTR modulators

Vertex Pharmaceuticals Incorporated · Granted Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8563576

Tri-cyclic pyrazolopyridine kinase inhibitors

Vertex Pharmaceuticals Incorporated · Granted Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8563593

Formulations of (R)-1-(2,2-difluorobenzo[D] [1,3] dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-

Vertex Pharmaceuticals Incorporated · Granted Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8557833

Aminopyrimidines useful as kinase inhibitors

Vertex Pharmaceuticals Incorporated · Granted Tue Oct 15 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8557818

Compounds useful as protein kinase inhibitors

Vertex Pharmaceuticals Incorporated · Granted Tue Oct 15 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 10 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8552034

Pharmaceutical compositions of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropane

Vertex Pharmaceuticals Incorporated · Granted Tue Oct 08 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8552006

Modulators of cystic fibrosis transmembrane conductance regulator

Vertex Pharmaceuticals Incorporated · Granted Tue Oct 08 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 03 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted